A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients.
Saved in:
| Title: | A pharmacogenetic interaction analysis of bevacizumab with paclitaxel in advanced breast cancer patients. |
|---|---|
| Authors: | Coltelli L; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy.; Division of Medical Oncology, Livorno and Pontedera Hospitals, Azienda USL Toscana Nord Ovest, Pisa, Italy., Allegrini G; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy.; Division of Medical Oncology, Livorno and Pontedera Hospitals, Azienda USL Toscana Nord Ovest, Pisa, Italy., Orlandi P; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Finale C; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy.; Division of Medical Oncology, Livorno and Pontedera Hospitals, Azienda USL Toscana Nord Ovest, Pisa, Italy., Fontana A; Division of Medical Oncology II, Azienda Ospedaliero-Universitaria Pisana, S. Chiara Hospital, Pisa, Italy., Masini LC; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy.; Division of Medical Oncology, Livorno and Pontedera Hospitals, Azienda USL Toscana Nord Ovest, Pisa, Italy., Scalese M; Institute of Clinical Physiology, Italian National Research Council - CNR, Pisa, Italy., Arrighi G; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy.; Division of Medical Oncology, Livorno and Pontedera Hospitals, Azienda USL Toscana Nord Ovest, Pisa, Italy., Barletta MT; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy.; Division of Medical Oncology, Livorno and Pontedera Hospitals, Azienda USL Toscana Nord Ovest, Pisa, Italy., De Maio E; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy.; Division of Medical Oncology, Livorno and Pontedera Hospitals, Azienda USL Toscana Nord Ovest, Pisa, Italy., Banchi M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Fini E; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Guidi P; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Frenzilli G; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy., Donati S; Division of Medical Oncology, Versilia Hospital, Azienda Usl Toscana Nord Ovest, Lido di Camaiore, Italy., Giovannelli S; Division of Medical Oncology, San Luca Hospital, Azienda Usl Toscana Nord Ovest, Lucca, Italy., Tanganelli L; Division of Medical Oncology, San Luca Hospital, Azienda Usl Toscana Nord Ovest, Lucca, Italy., Salvadori B; Division of Medical Oncology II, Azienda Ospedaliero-Universitaria Pisana, S. Chiara Hospital, Pisa, Italy., Livi L; Division of Radiotherapy, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy., Meattini I; Division of Radiotherapy, Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy., Pazzagli I; Division of Medical Oncology, Pescia and Pistoia Hospitals, Azienda Usl Toscana Centro, Pistoia, Italy., Di Lieto M; Division of Medical Oncology, Pescia and Pistoia Hospitals, Azienda Usl Toscana Centro, Pistoia, Italy., Pistelli M; Division of Medical Oncology, Umberto I Salesi-Lancisi Hospital, Azienda Ospedaliero-Universitaria Umberto I, Ancona, Italy., Casadei V; Division of Medical Oncology, Marche Nord Hospital, Azienda Ospedaliera San Salvatore, Pesaro, Italy., Ferro A; Division of Medical Oncology, Santa Chiara Hospital, Azienda Provinciale per I Servizi Sanitari, Trento, Italy., Cupini S; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy.; Division of Medical Oncology, Livorno and Pontedera Hospitals, Azienda USL Toscana Nord Ovest, Pisa, Italy., Orlandi F; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy.; Division of Medical Oncology, Livorno and Pontedera Hospitals, Azienda USL Toscana Nord Ovest, Pisa, Italy., Francesca D; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy.; Division of Radiology, Pontedera Hospital, Azienda Usl Toscana Nord Ovest, Pisa, Italy., Lorenzini G; Division of Medical Oncology II, Azienda Ospedaliero-Universitaria Pisana, S. Chiara Hospital, Pisa, Italy., Barellini L; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy.; Breast Unit - Division of Breast Surgery, Livorno Hospital, Azienda Usl Toscana Nord Ovest, Livorno, Italy., Falcone A; Division of Medical Oncology II, Azienda Ospedaliero-Universitaria Pisana, S. Chiara Hospital, Pisa, Italy.; Department of Translational Research and New Technology in Medicine and Surgery, University of Pisa, Pisa, Italy., Cosimi A; Department of Oncology, Azienda USL Toscana Nord Ovest, Pisa, Italy., Bocci G; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. guido.bocci@unipi.it. |
| Source: | NPJ breast cancer [NPJ Breast Cancer] 2022 Mar 21; Vol. 8 (1), pp. 33. Date of Electronic Publication: 2022 Mar 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
